nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Azotaemia—Vincristine—muscle cancer	0.0269	0.0269	CcSEcCtD
Vancomycin—Necrosis—Dactinomycin—muscle cancer	0.0204	0.0204	CcSEcCtD
Vancomycin—Nephropathy toxic—Etoposide—muscle cancer	0.0202	0.0202	CcSEcCtD
Vancomycin—Extravasation—Dactinomycin—muscle cancer	0.0184	0.0184	CcSEcCtD
Vancomycin—Injection site inflammation—Doxorubicin—muscle cancer	0.018	0.018	CcSEcCtD
Vancomycin—Extravasation—Vincristine—muscle cancer	0.0164	0.0164	CcSEcCtD
Vancomycin—Necrosis—Etoposide—muscle cancer	0.0148	0.0148	CcSEcCtD
Vancomycin—Rigors—Etoposide—muscle cancer	0.0142	0.0142	CcSEcCtD
Vancomycin—Phlebitis—Dactinomycin—muscle cancer	0.0135	0.0135	CcSEcCtD
Vancomycin—Extravasation—Etoposide—muscle cancer	0.0133	0.0133	CcSEcCtD
Vancomycin—Azotaemia—Methotrexate—muscle cancer	0.013	0.013	CcSEcCtD
Vancomycin—Kidney function abnormal—Doxorubicin—muscle cancer	0.0124	0.0124	CcSEcCtD
Vancomycin—Deafness—Vincristine—muscle cancer	0.0116	0.0116	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0105	0.0105	CcSEcCtD
Vancomycin—Serum creatinine increased—Doxorubicin—muscle cancer	0.00978	0.00978	CcSEcCtD
Vancomycin—Phlebitis—Etoposide—muscle cancer	0.00977	0.00977	CcSEcCtD
Vancomycin—Neutropenia—Dactinomycin—muscle cancer	0.0094	0.0094	CcSEcCtD
Vancomycin—Fungal infection—Methotrexate—muscle cancer	0.00899	0.00899	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00888	0.00888	CcSEcCtD
Vancomycin—Necrosis—Methotrexate—muscle cancer	0.00885	0.00885	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Etoposide—muscle cancer	0.0087	0.0087	CcSEcCtD
Vancomycin—Neutropenia—Vincristine—muscle cancer	0.0084	0.0084	CcSEcCtD
Vancomycin—Agranulocytosis—Dactinomycin—muscle cancer	0.00836	0.00836	CcSEcCtD
Vancomycin—Extravasation—Methotrexate—muscle cancer	0.00796	0.00796	CcSEcCtD
Vancomycin—Fungal infection—Doxorubicin—muscle cancer	0.00779	0.00779	CcSEcCtD
Vancomycin—Necrosis—Doxorubicin—muscle cancer	0.00766	0.00766	CcSEcCtD
Vancomycin—Erythema multiforme—Dactinomycin—muscle cancer	0.00761	0.00761	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00758	0.00758	CcSEcCtD
Vancomycin—Flushing—Dactinomycin—muscle cancer	0.00747	0.00747	CcSEcCtD
Vancomycin—Rigors—Doxorubicin—muscle cancer	0.00737	0.00737	CcSEcCtD
Vancomycin—Chills—Dactinomycin—muscle cancer	0.00722	0.00722	CcSEcCtD
Vancomycin—Vasculitis—Methotrexate—muscle cancer	0.00712	0.00712	CcSEcCtD
Vancomycin—Connective tissue disorder—Vincristine—muscle cancer	0.00706	0.00706	CcSEcCtD
Vancomycin—Erythema—Dactinomycin—muscle cancer	0.007	0.007	CcSEcCtD
Vancomycin—Extravasation—Doxorubicin—muscle cancer	0.00689	0.00689	CcSEcCtD
Vancomycin—Neutropenia—Etoposide—muscle cancer	0.0068	0.0068	CcSEcCtD
Vancomycin—Infestation—Etoposide—muscle cancer	0.00649	0.00649	CcSEcCtD
Vancomycin—Infestation NOS—Etoposide—muscle cancer	0.00649	0.00649	CcSEcCtD
Vancomycin—Anaemia—Dactinomycin—muscle cancer	0.00647	0.00647	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00643	0.00643	CcSEcCtD
Vancomycin—Renal failure—Etoposide—muscle cancer	0.00638	0.00638	CcSEcCtD
Vancomycin—Creatinine increased—Doxorubicin—muscle cancer	0.00632	0.00632	CcSEcCtD
Vancomycin—Agranulocytosis—Etoposide—muscle cancer	0.00605	0.00605	CcSEcCtD
Vancomycin—Back pain—Vincristine—muscle cancer	0.00605	0.00605	CcSEcCtD
Vancomycin—Thrombophlebitis—Methotrexate—muscle cancer	0.00582	0.00582	CcSEcCtD
Vancomycin—Anaemia—Vincristine—muscle cancer	0.00578	0.00578	CcSEcCtD
Vancomycin—Infection—Dactinomycin—muscle cancer	0.00568	0.00568	CcSEcCtD
Vancomycin—Vertigo—Vincristine—muscle cancer	0.00562	0.00562	CcSEcCtD
Vancomycin—Thrombocytopenia—Dactinomycin—muscle cancer	0.0056	0.0056	CcSEcCtD
Vancomycin—Erythema multiforme—Etoposide—muscle cancer	0.00551	0.00551	CcSEcCtD
Vancomycin—Flushing—Etoposide—muscle cancer	0.0054	0.0054	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00534	0.00534	CcSEcCtD
Vancomycin—Chills—Etoposide—muscle cancer	0.00522	0.00522	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00521	0.00521	CcSEcCtD
Vancomycin—Anaphylactic shock—Vincristine—muscle cancer	0.00511	0.00511	CcSEcCtD
Vancomycin—Infection—Vincristine—muscle cancer	0.00507	0.00507	CcSEcCtD
Vancomycin—Phlebitis—Doxorubicin—muscle cancer	0.00507	0.00507	CcSEcCtD
Vancomycin—Thrombophlebitis—Doxorubicin—muscle cancer	0.00504	0.00504	CcSEcCtD
Vancomycin—Nervous system disorder—Vincristine—muscle cancer	0.00501	0.00501	CcSEcCtD
Vancomycin—Thrombocytopenia—Vincristine—muscle cancer	0.005	0.005	CcSEcCtD
Vancomycin—Fatigue—Dactinomycin—muscle cancer	0.00493	0.00493	CcSEcCtD
Vancomycin—Back pain—Etoposide—muscle cancer	0.0049	0.0049	CcSEcCtD
Vancomycin—Pain—Dactinomycin—muscle cancer	0.00489	0.00489	CcSEcCtD
Vancomycin—Muscle spasms—Etoposide—muscle cancer	0.00487	0.00487	CcSEcCtD
Vancomycin—Hypotension—Vincristine—muscle cancer	0.00477	0.00477	CcSEcCtD
Vancomycin—Anaemia—Etoposide—muscle cancer	0.00468	0.00468	CcSEcCtD
Vancomycin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00467	0.00467	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00463	0.00463	CcSEcCtD
Vancomycin—Insomnia—Vincristine—muscle cancer	0.00462	0.00462	CcSEcCtD
Vancomycin—Renal impairment—Doxorubicin—muscle cancer	0.00459	0.00459	CcSEcCtD
Vancomycin—Dermatitis bullous—Doxorubicin—muscle cancer	0.00457	0.00457	CcSEcCtD
Vancomycin—Vertigo—Etoposide—muscle cancer	0.00455	0.00455	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00454	0.00454	CcSEcCtD
Vancomycin—Abdominal pain—Dactinomycin—muscle cancer	0.00452	0.00452	CcSEcCtD
Vancomycin—Body temperature increased—Dactinomycin—muscle cancer	0.00452	0.00452	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00451	0.00451	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Vincristine—muscle cancer	0.00441	0.00441	CcSEcCtD
Vancomycin—Fatigue—Vincristine—muscle cancer	0.0044	0.0044	CcSEcCtD
Vancomycin—Constipation—Vincristine—muscle cancer	0.00437	0.00437	CcSEcCtD
Vancomycin—Pain—Vincristine—muscle cancer	0.00437	0.00437	CcSEcCtD
Vancomycin—Eosinophilia—Methotrexate—muscle cancer	0.00431	0.00431	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00429	0.00429	CcSEcCtD
Vancomycin—Hypersensitivity—Dactinomycin—muscle cancer	0.00421	0.00421	CcSEcCtD
Vancomycin—Gastrointestinal pain—Vincristine—muscle cancer	0.00418	0.00418	CcSEcCtD
Vancomycin—Anaphylactic shock—Etoposide—muscle cancer	0.00414	0.00414	CcSEcCtD
Vancomycin—Infection—Etoposide—muscle cancer	0.00411	0.00411	CcSEcCtD
Vancomycin—Asthenia—Dactinomycin—muscle cancer	0.0041	0.0041	CcSEcCtD
Vancomycin—Blood creatinine increased—Doxorubicin—muscle cancer	0.00409	0.00409	CcSEcCtD
Vancomycin—Neutropenia—Methotrexate—muscle cancer	0.00407	0.00407	CcSEcCtD
Vancomycin—Thrombocytopenia—Etoposide—muscle cancer	0.00405	0.00405	CcSEcCtD
Vancomycin—Tachycardia—Etoposide—muscle cancer	0.00404	0.00404	CcSEcCtD
Vancomycin—Body temperature increased—Vincristine—muscle cancer	0.00404	0.00404	CcSEcCtD
Vancomycin—Abdominal pain—Vincristine—muscle cancer	0.00404	0.00404	CcSEcCtD
Vancomycin—Skin disorder—Etoposide—muscle cancer	0.00402	0.00402	CcSEcCtD
Vancomycin—Hypokalaemia—Doxorubicin—muscle cancer	0.00397	0.00397	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00393	0.00393	CcSEcCtD
Vancomycin—Infestation NOS—Methotrexate—muscle cancer	0.00389	0.00389	CcSEcCtD
Vancomycin—Infestation—Methotrexate—muscle cancer	0.00389	0.00389	CcSEcCtD
Vancomycin—Hypotension—Etoposide—muscle cancer	0.00387	0.00387	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00385	0.00385	CcSEcCtD
Vancomycin—Renal failure—Methotrexate—muscle cancer	0.00382	0.00382	CcSEcCtD
Vancomycin—Hypersensitivity—Vincristine—muscle cancer	0.00376	0.00376	CcSEcCtD
Vancomycin—Eosinophilia—Doxorubicin—muscle cancer	0.00374	0.00374	CcSEcCtD
Vancomycin—Dyspnoea—Etoposide—muscle cancer	0.00369	0.00369	CcSEcCtD
Vancomycin—Asthenia—Vincristine—muscle cancer	0.00366	0.00366	CcSEcCtD
Vancomycin—Vomiting—Dactinomycin—muscle cancer	0.00363	0.00363	CcSEcCtD
Vancomycin—Agranulocytosis—Methotrexate—muscle cancer	0.00363	0.00363	CcSEcCtD
Vancomycin—Rash—Dactinomycin—muscle cancer	0.0036	0.0036	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Etoposide—muscle cancer	0.00357	0.00357	CcSEcCtD
Vancomycin—Fatigue—Etoposide—muscle cancer	0.00357	0.00357	CcSEcCtD
Vancomycin—Pain—Etoposide—muscle cancer	0.00354	0.00354	CcSEcCtD
Vancomycin—Constipation—Etoposide—muscle cancer	0.00354	0.00354	CcSEcCtD
Vancomycin—Neutropenia—Doxorubicin—muscle cancer	0.00353	0.00353	CcSEcCtD
Vancomycin—Nausea—Dactinomycin—muscle cancer	0.00339	0.00339	CcSEcCtD
Vancomycin—Gastrointestinal pain—Etoposide—muscle cancer	0.00338	0.00338	CcSEcCtD
Vancomycin—Dizziness—Vincristine—muscle cancer	0.00338	0.00338	CcSEcCtD
Vancomycin—Infestation—Doxorubicin—muscle cancer	0.00336	0.00336	CcSEcCtD
Vancomycin—Infestation NOS—Doxorubicin—muscle cancer	0.00336	0.00336	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00334	0.00334	CcSEcCtD
Vancomycin—Renal failure—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Vancomycin—Erythema multiforme—Methotrexate—muscle cancer	0.0033	0.0033	CcSEcCtD
Vancomycin—Urticaria—Etoposide—muscle cancer	0.00329	0.00329	CcSEcCtD
Vancomycin—Abdominal pain—Etoposide—muscle cancer	0.00327	0.00327	CcSEcCtD
Vancomycin—Body temperature increased—Etoposide—muscle cancer	0.00327	0.00327	CcSEcCtD
Vancomycin—Urinary tract infection—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Vancomycin—Tinnitus—Methotrexate—muscle cancer	0.00325	0.00325	CcSEcCtD
Vancomycin—Vomiting—Vincristine—muscle cancer	0.00325	0.00325	CcSEcCtD
Vancomycin—Rash—Vincristine—muscle cancer	0.00322	0.00322	CcSEcCtD
Vancomycin—Dermatitis—Vincristine—muscle cancer	0.00322	0.00322	CcSEcCtD
Vancomycin—Headache—Vincristine—muscle cancer	0.0032	0.0032	CcSEcCtD
Vancomycin—Agranulocytosis—Doxorubicin—muscle cancer	0.00314	0.00314	CcSEcCtD
Vancomycin—Chills—Methotrexate—muscle cancer	0.00313	0.00313	CcSEcCtD
Vancomycin—Bradycardia—Doxorubicin—muscle cancer	0.00307	0.00307	CcSEcCtD
Vancomycin—Hypersensitivity—Etoposide—muscle cancer	0.00305	0.00305	CcSEcCtD
Vancomycin—Malnutrition—Methotrexate—muscle cancer	0.00304	0.00304	CcSEcCtD
Vancomycin—Erythema—Methotrexate—muscle cancer	0.00304	0.00304	CcSEcCtD
Vancomycin—Nausea—Vincristine—muscle cancer	0.00303	0.00303	CcSEcCtD
Vancomycin—Oedema peripheral—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Vancomycin—Asthenia—Etoposide—muscle cancer	0.00297	0.00297	CcSEcCtD
Vancomycin—Connective tissue disorder—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Vancomycin—Back pain—Methotrexate—muscle cancer	0.00294	0.00294	CcSEcCtD
Vancomycin—Pruritus—Etoposide—muscle cancer	0.00293	0.00293	CcSEcCtD
Vancomycin—Erythema multiforme—Doxorubicin—muscle cancer	0.00286	0.00286	CcSEcCtD
Vancomycin—Tinnitus—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Vancomycin—Anaemia—Methotrexate—muscle cancer	0.00281	0.00281	CcSEcCtD
Vancomycin—Flushing—Doxorubicin—muscle cancer	0.0028	0.0028	CcSEcCtD
Vancomycin—Dizziness—Etoposide—muscle cancer	0.00274	0.00274	CcSEcCtD
Vancomycin—Vertigo—Methotrexate—muscle cancer	0.00273	0.00273	CcSEcCtD
Vancomycin—Chills—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Vancomycin—Vomiting—Etoposide—muscle cancer	0.00263	0.00263	CcSEcCtD
Vancomycin—Malnutrition—Doxorubicin—muscle cancer	0.00263	0.00263	CcSEcCtD
Vancomycin—Erythema—Doxorubicin—muscle cancer	0.00263	0.00263	CcSEcCtD
Vancomycin—Rash—Etoposide—muscle cancer	0.00261	0.00261	CcSEcCtD
Vancomycin—Dermatitis—Etoposide—muscle cancer	0.00261	0.00261	CcSEcCtD
Vancomycin—Headache—Etoposide—muscle cancer	0.00259	0.00259	CcSEcCtD
Vancomycin—Flatulence—Doxorubicin—muscle cancer	0.00259	0.00259	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Vancomycin—Back pain—Doxorubicin—muscle cancer	0.00254	0.00254	CcSEcCtD
Vancomycin—Muscle spasms—Doxorubicin—muscle cancer	0.00253	0.00253	CcSEcCtD
Vancomycin—Anaphylactic shock—Methotrexate—muscle cancer	0.00248	0.00248	CcSEcCtD
Vancomycin—Infection—Methotrexate—muscle cancer	0.00246	0.00246	CcSEcCtD
Vancomycin—Nausea—Etoposide—muscle cancer	0.00246	0.00246	CcSEcCtD
Vancomycin—Nervous system disorder—Methotrexate—muscle cancer	0.00243	0.00243	CcSEcCtD
Vancomycin—Anaemia—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Vancomycin—Thrombocytopenia—Methotrexate—muscle cancer	0.00243	0.00243	CcSEcCtD
Vancomycin—Skin disorder—Methotrexate—muscle cancer	0.00241	0.00241	CcSEcCtD
Vancomycin—Vertigo—Doxorubicin—muscle cancer	0.00236	0.00236	CcSEcCtD
Vancomycin—Palpitations—Doxorubicin—muscle cancer	0.00232	0.00232	CcSEcCtD
Vancomycin—Hypotension—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Vancomycin—Insomnia—Methotrexate—muscle cancer	0.00224	0.00224	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Vancomycin—Dyspnoea—Methotrexate—muscle cancer	0.00221	0.00221	CcSEcCtD
Vancomycin—Anaphylactic shock—Doxorubicin—muscle cancer	0.00215	0.00215	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Vancomycin—Fatigue—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Vancomycin—Infection—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Vancomycin—Pain—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Vancomycin—Nervous system disorder—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Vancomycin—Thrombocytopenia—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Vancomycin—Tachycardia—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Vancomycin—Skin disorder—Doxorubicin—muscle cancer	0.00208	0.00208	CcSEcCtD
Vancomycin—Gastrointestinal pain—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Vancomycin—Hypotension—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Vancomycin—Urticaria—Methotrexate—muscle cancer	0.00197	0.00197	CcSEcCtD
Vancomycin—Body temperature increased—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Vancomycin—Abdominal pain—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Vancomycin—Insomnia—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Vancomycin—Dyspnoea—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Vancomycin—Fatigue—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Vancomycin—Pain—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Constipation—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Hypersensitivity—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Asthenia—Methotrexate—muscle cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Vancomycin—Pruritus—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Vancomycin—Urticaria—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Body temperature increased—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Abdominal pain—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Dizziness—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Hypersensitivity—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Vomiting—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Rash—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Vancomycin—Dermatitis—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Vancomycin—Headache—Methotrexate—muscle cancer	0.00155	0.00155	CcSEcCtD
Vancomycin—Asthenia—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Pruritus—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Nausea—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Vancomycin—Dizziness—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Vomiting—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Vancomycin—Rash—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Dermatitis—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Headache—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Nausea—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
